Jan. 30, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ ... In the overall study population, TX45 achieved a 17.9% reduction in pulmonary capillary wedge pressure (“PCWP”), an endpoint ...

Available in either an eight-inch or 10-inch height, this wedge cushion features a top layer of therapeutic gel memory foam that can help disperse heat and keep you cool while you sleep.

Investing.com -- Shares of Tectonic Therapeutic, Inc. (NASDAQ ... that TX45 achieved a 17.9% reduction in Pulmonary Capillary Wedge Pressure (PCWP) across the study population.

The trial's safety results were reassuring, with no serious adverse events or significant changes in vital signs, physical exams, or safety laboratory values post-administration of TX45. Transient ...

TX45 improved both left ventricular function and pulmonary hemodynamics in patients with Group 2 Pulmonary Hypertension in Heart Failure with preserved Ejection Fraction (“PH-HFpEF”), supporting endpo ...

Tectonic Therapeutic shares doubled ... TX45 achieved a 17.9% reduction in pulmonary capillary wedge pressure, an endpoint known to correlate with exercise capacity, morbidity and mortality ...

Tectonic Therapeutic has done well to advance its Fc-fusion protein candidate TX45 into a phase 2 study targeting patients ...

Whenever Valentine’s Day rolls around, restaurant menus are filled with oyster appetisers and chocolate sweets for dessert.

Renard Spivey: Actually, during that period of time, it was more therapeutic for me 'cause I ... It was more so trying to just put that wedge, uh, between the two of us. And it worked.